Humana Stock News

Highland Capital Management LLC raised its position in Humana Inc. (NYSE:HUM) by 0.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,861 shares of the insurance providers stock after buying an additional 61 shares during the period. Highland Capital Management []

Humana Inc. (NYSE:HUM) has been assigned an average rating of Buy from the eighteen research firms that are presently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have []

I present my top 15 high-growth dividend stocks to consider during the month of December.

Regent Investment Management LLC cut its holdings in Humana Inc. (NYSE:HUM) by 1.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,460 shares of the insurance providers stock after selling 55 shares during the quarter. Regent Investment Management LLCs holdings in Humana []

Humana Inc. (NYSE:HUM) has earned an average rating of Buy from the eighteen analysts that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on []

Humana (NYSE:HUM) updated its FY21 earnings guidance on Wednesday. The company provided EPS guidance of $20.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $20.62. Humana also updated its FY 2021 guidance to $20.500-$20.500 EPS. A number of brokerages recently commented on HUM. Oppenheimer upped their target price on Humana from []

Venturi Wealth Management LLC trimmed its holdings in Humana Inc. (NYSE:HUM) by 7.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,591 shares of the insurance providers stock after selling 213 shares during the quarter. Venturi Wealth Management LLCs holdings in Humana were worth []

Humana (HUM) forges an alliance with the Loudoun Medical Group to boost its Medicare Advantage portfolio.

Central Bank & Trust Co. lowered its position in shares of Humana Inc. (NYSE:HUM) by 2.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,415 shares of the insurance provider’s stock after selling 112 shares during the period. Central Bank & […]

Pacer Advisors Inc. lessened its stake in Humana Inc. (NYSE:HUM) by 9.8% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 8,385 shares of the insurance providers stock after selling 910 shares during the quarter. Pacer Advisors Inc.s holdings in Humana were worth $3,263,000 at the end of the most recent reporting period. Other []

Viking Global leader Andreas Halvorsen (Trades, Portfolio) disclosed his portfolio for the third quarter in November.

Frontier Capital Management Co. LLC lifted its position in Humana Inc. (NYSE:HUM) by 76.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 140,316 shares of the insurance providers stock after acquiring an additional 60,573 shares during the quarter. []

Canton Hathaway LLC acquired a new stake in Humana Inc. (NYSE:HUM) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 134 shares of the insurance providers stock, valued at approximately $52,000. A number of other hedge funds also recently []

- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, and Asia -based global healthcare investors Tybourne Capital Management and NSG Ventures - Following the most recent strategic investment of $26 million from Guardant Health, the company has now secured more than $135 million in total ahead of its planned KOSDAQ IPO next year SEOUL, South Korea , Nov. 25, 2021 /PRNewswire/ -- Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company''s planned public offering on the South Korean stock market (KOSDAQ) early next year. A number of new investors have joined the round including leading US healthcare investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, as well as Asia -based global healthcare investors Tybourne Capital Management, and NSG Ventures. HealthQuest Capital invested $20 million of the total funding amount.

Humana (HUM) expands value-based agreement with Allina Health, which is aimed at offering enhanced outcomes for HUM's MA members in Minnesota.